Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Shares Issued (2019 - 2025)

Volitionrx (VNRX) has disclosed Shares Issued for 9 consecutive years, with -$28597.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued rose 95.27% year-over-year to -$28597.0, compared with a TTM value of $14.4 million through Sep 2025, up 454.18%, and an annual FY2024 reading of $8.6 million, down 69.73% over the prior year.
  • Shares Issued was -$28597.0 for Q3 2025 at Volitionrx, down from $3.4 million in the prior quarter.
  • Across five years, Shares Issued topped out at $19.4 million in Q2 2021 and bottomed at -$605222.0 in Q3 2024.
  • Average Shares Issued over 5 years is $3.8 million, with a median of $1.8 million recorded in 2021.
  • The sharpest move saw Shares Issued surged 581785633.33% in 2023, then tumbled 607.31% in 2024.
  • Year by year, Shares Issued stood at $1.8 million in 2021, then crashed by 56.15% to $781794.0 in 2022, then skyrocketed by 231.59% to $2.6 million in 2023, then soared by 231.44% to $8.6 million in 2024, then plummeted by 100.33% to -$28597.0 in 2025.
  • Business Quant data shows Shares Issued for VNRX at -$28597.0 in Q3 2025, $3.4 million in Q2 2025, and $2.4 million in Q1 2025.